Why Oscar Health (OSCR) Went Up on Tuesday?

Insider Monkey
02-19

We recently published a list of 10 Firms Kick Off Shortened Trading Week With Impressive Gains. In this article, we are going to take a look at where Oscar Health, Inc. (NYSE:OSCR) stands against firms that kick off shortened trading week with impressive gains.

The stock market kicked off the shortened trading week on a positive note, with all major indices finishing in the green territory as investors continued to monitor more corporate earnings results.

The S&P 500 led the charge among its peers, recording a modest 0.24 percent gain. The Dow Jones and the tech-heavy Nasdaq were similarly up, albeit posting lackluster gains of only 0.02 percent and 0.07 percent, respectively.

In comparison, 10 companies delivered stronger performances thanks to continued investor confidence. One company in particular stood out for jumping more than 100 percent in just two trading days.

To come up with Tuesday’s top performers, we considered only the stocks with at least $2 billion in market capitalization and $5 million in daily trading volume.

A close up of a patient and a healthcare professional engaging in conversation, showing the company's commitment to patient care.

Oscar Health, Inc. (NYSE:OSCR)

Oscar Health, Inc. (NYSE:OSCR) saw its share prices surge by 17.76 percent on Tuesday to finish at $15.85 apiece as investors resumed bargain-hunting after hitting a new all-time low last week.

Last Thursday, OSCR fell to its lowest in a year at $12.43 apiece, before bargain-hunting began pushing the company’s share prices higher on Friday.

In recent news, Oscar Health (NYSE:OSCR) reported mixed earnings performance in the fourth quarter of 2024.

In three months ending December 2024, Oscar Health (NYSE:OSCR) said net loss expanded to $153 million from the $150 million registered in the same period a year ago. However, it swung to a net income of $25.4 million in full-year 2024 from a $271 million net loss in 2023.

Revenues for both the fourth quarter and full year came in higher by 67 percent and 57 percent, respectively.

For this year, Oscar Health said it targets to book between $11.2 billion and $11.3 billion in total revenues, or an increase of 23 percent year-on-year.

Overall, OSCR ranks 2nd on our list of firms that kick off shortened trading week with impressive gains. While we acknowledge the potential of OSCR as an investment, our conviction lies in the belief that AI stocks hold greater promise for delivering higher returns and doing so within a shorter time frame. If you are looking for an AI stock that is more promising than OSCR but that trades at less than 5 times its earnings, check out our report about the cheapest AI stock.

READ NEXT: 20 Best AI Stocks To Buy Now and Complete List of 59 AI Companies Under $2 Billion in Market Cap

Disclosure: None. This article is originally published at Insider Monkey.

免责声明:投资有风险,本文并非投资建议,以上内容不应被视为任何金融产品的购买或出售要约、建议或邀请,作者或其他用户的任何相关讨论、评论或帖子也不应被视为此类内容。本文仅供一般参考,不考虑您的个人投资目标、财务状况或需求。TTM对信息的准确性和完整性不承担任何责任或保证,投资者应自行研究并在投资前寻求专业建议。

热议股票

  1. 1
     
     
     
     
  2. 2
     
     
     
     
  3. 3
     
     
     
     
  4. 4
     
     
     
     
  5. 5
     
     
     
     
  6. 6
     
     
     
     
  7. 7
     
     
     
     
  8. 8
     
     
     
     
  9. 9
     
     
     
     
  10. 10